VTB Medicine, an international medical tourism platform, is developing a new product in the field of assisted reproductive technologies (ART) for patients from China. This was announced by Arsen Shiroyan, Commercial Director of VTB Medicine, at the Business Forum SPROUTS in Kazan, dedicated to cooperation between Russia and China.
Russia is among the global leaders in several medical fields, including obstetrics and gynecology. The country employs advanced ART methods such as ICSI, PGT-A, embryo scopes, and microfluidic chips. Together with its partners, VTB Medicine offers Chinese couples a treatment pathway to Russian clinics, where modern technologies and comprehensive support at all stages of treatment are available.
"We are seeing high demand for ART among Chinese families. For couples planning treatment abroad, not only advanced technologies matter, but also a clear treatment pathway, reliable organization, and support at every stage. We are creating a product that addresses these needs—from the initial consultation and selection of a specialized clinic to logistics, stay in Russia, and follow-up care after returning home," said Arsen Shiroyan, Commercial Director of VTB Medicine.